Globus Medical

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Globus Medical and other ETFs, options, and stocks.

About GMED

Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. It engages in developing products that promote healing in patients with musculoskeletal disorders. 

CEO
Keith W. Pfeil
CEOKeith W. Pfeil
Employees
6,000
Employees6,000
Headquarters
Audubon, Pennsylvania
HeadquartersAudubon, Pennsylvania
Founded
2003
Founded2003
Employees
6,000
Employees6,000

GMED Key Statistics

Market cap
11.14B
Market cap11.14B
Price-Earnings ratio
19.20
Price-Earnings ratio19.20
Dividend yield
Dividend yield
Average volume
1.94M
Average volume1.94M
High today
$82.93
High today$82.93
Low today
$81.57
Low today$81.57
Open price
$82.61
Open price$82.61
Volume
204.49K
Volume204.49K
52 Week high
$101.40
52 Week high$101.40
52 Week low
$51.79
52 Week low$51.79

Stock Snapshot

As of today, Globus Medical(GMED) shares are valued at $82.12. The company's market cap stands at 11.14B, with a P/E ratio of 19.20.

During the trading session on 2026-05-29, Globus Medical(GMED) shares reached a daily high of $82.93 and a low of $81.57. At a current price of $82.12, the stock is +0.7% higher than the low and still -1.0% under the high.

Trading volume for Globus Medical(GMED) stock has reached 204.49K, versus its average volume of 1.94M.

Over the past 52 weeks, Globus Medical(GMED) stock has traded between a high of $101.40 and a low of $51.79.

Over the past 52 weeks, Globus Medical(GMED) stock has traded between a high of $101.40 and a low of $51.79.

GMED News

Zacks 1d
GMED Growth Drivers After NuVasive and What Q1 Signals - Zacks Investment Research

...

GMED Growth Drivers After NuVasive and What Q1 Signals - Zacks Investment Research
Nasdaq 4d
Veracyte Stock Surges 65.8% in a Year: What's Driving the Rally?

Veracyte’s VCYT shares have surged 65.8% over the past year, showing impressive momentum. It has significantly outperformed the industry’s 4.8% decline and the...

Veracyte Stock Surges 65.8% in a Year: What's Driving the Rally?
Nasdaq 4d
Omnicell Stock Surges 57.3% in a Year: What's Driving It?

Omnicell OMCL has seen impressive growth over the past year, with its shares jumping 57.3%. It has significantly outperformed the industry’s 30.3% fall and the...

Omnicell Stock Surges 57.3% in a Year: What's Driving It?

Analyst ratings

69%

of 16 ratings
Buy
68.8%
Hold
31.3%
Sell
0%

More GMED News

Simply Wall St 4d
Globus Medical Is Up 7.4% After Q1 Beat And AI-Driven Margin Expansion Push - What's Changed

Globus Medical recently reported a strong first quarter, beating earnings and revenue expectations, expanding adjusted EBITDA margins and raising full-year non-...

Globus Medical Is Up 7.4% After Q1 Beat And AI-Driven Margin Expansion Push - What's Changed
Simply Wall St 6d
Is It Time To Reassess Globus Medical After Recent Share Price Swings?

Investors may be wondering whether Globus Medical at around US$84.81 is offering good value right now, or whether the recent excitement has already been priced...

Is It Time To Reassess Globus Medical After Recent Share Price Swings?

People also own

Based on the portfolios of people who own GMED. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.